A clinical study was carried out on imipenem/cilastatin sodium (IPM/CS) in the perinatal period, and the results obtained are summarized as follows. IPM/CS was given to 5 cases with puerperal intrauterine infection and 2 with puerperal fever. The clinical efficacies were evaluated as good in 6 cases and poor in 1. The clinical efficacy rate was 85.7%. In a bacteriological examination, 9 strains were isolated from 6 cases, and 7 strains were eradicated with an eradication rate of 77.8%. No side effects were observed in any of the cases treated with IPM/CS.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
imipenem/cilastatin sodium
8
[clinical study
4
study imipenem/cilastatin
4
sodium perinatal
4
perinatal period]
4
period] clinical
4
clinical study
4
study carried
4
carried imipenem/cilastatin
4
sodium ipm/cs
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!